DNTH vs PG
Dianthus Therapeutics Inc. (DNTH) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
DNTH currently screens at market cap $4.40B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the DNTH and PG stock pages for the full models.
Not investment advice.